Product Information
CLINDAMYC-BNZ PEROX 1.2-3.75% is a generic product labeled by Oceanside Pharmaceuticals, priced at $3.6862 per GM under NDC 68682013350. Its NADAC has been published 90 times since Jan 17, 2024.
FDA first approved this application on Oct 23, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5; 10 mg/g; mg/g
Manufacturer
Oceanside PharmaceuticalsNDC
68682013350
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/17/2025
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA050819FDA Approved
10/23/2008
TE Code
AB
On Market Since
10/2/2023
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has been published 90 times since Jan 17, 2024, and over the history we have for it it has declined 39.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6862 per GM |
|---|---|
| All-time high | $7.6354 (Apr 10, 2024) |
| All-time low | $3.6862 (Sep 17, 2025) |
| Median price | $4.7057 |
| Average price | $4.9152 |
| Largest weekly change | -45.1% (Apr 17, 2024) |
| Weeks tracked | 90 |
| Tracking since | Jan 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-39.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Phosphate and Benzoyl Peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYC-BNZ PEROX 1.2-3.75%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYC-BNZ PEROX 1.2-3.75%, manufactured by Oceanside Pharmaceuticals, is $3.6862 per GM (NDC 68682013350), effective Oct 1, 2025.
How has the price of CLINDAMYC-BNZ PEROX 1.2-3.75% changed over time?
Over the history we have for it, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has declined 39.3%. It has been tracked across 90 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for CLINDAMYC-BNZ PEROX 1.2-3.75%?
Since Jan 17, 2024, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has ranged from a low of $3.6862 (Sep 17, 2025) to a high of $7.6354 (Apr 10, 2024), with a median of $4.7057 per GM.
Are there cheaper alternatives to CLINDAMYC-BNZ PEROX 1.2-3.75%?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYC-BNZ PEROX 1.2-3.75%, is $2.3440 per GM — about 36% below CLINDAMYC-BNZ PEROX 1.2-3.75%.
Who manufactures CLINDAMYC-BNZ PEROX 1.2-3.75%?
CLINDAMYC-BNZ PEROX 1.2-3.75% (NDC 68682013350) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.